(NASDAQ: CERS) Cerus's forecast annual revenue growth rate of 3.26% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.04%.
Cerus's revenue in 2025 is $201,321,000.On average, 1 Wall Street analysts forecast CERS's revenue for 2025 to be $36,786,383,370, with the lowest CERS revenue forecast at $36,786,383,370, and the highest CERS revenue forecast at $36,786,383,370. On average, 1 Wall Street analysts forecast CERS's revenue for 2026 to be $39,870,494,299, with the lowest CERS revenue forecast at $39,870,494,299, and the highest CERS revenue forecast at $39,870,494,299.
In 2027, CERS is forecast to generate $42,991,763,191 in revenue, with the lowest revenue forecast at $42,991,763,191 and the highest revenue forecast at $42,991,763,191.